Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Calcium Phosphate and Incretins

This study has been completed.
Information provided by (Responsible Party):
Gerhard Jahreis, University of Jena Identifier:
First received: February 15, 2011
Last updated: November 6, 2012
Last verified: November 2012
The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Condition Intervention
Healthy Men
Dietary Supplement: calcium phosphate
Other: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Influence of a Calcium Phosphate Supplementation on the Secretion of Incretins in Humans.

Resource links provided by NLM:

Further study details as provided by University of Jena:

Primary Outcome Measures:
  • secretion of incretins [ Time Frame: 3 weeks ]

Secondary Outcome Measures:
  • concentration of minerals in plasma [ Time Frame: 3 weeks ]

Enrollment: 10
Study Start Date: July 2010
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: calcium phosphate Dietary Supplement: calcium phosphate
the subjects consumed for 3 weeks a bread enriched with 1 g pentacalcium phosphate per day
Placebo Comparator: placebo Other: placebo
the subjects consumed a bread without pentacalcium phosphate


Ages Eligible for Study:   20 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • healthy men

Exclusion Criteria:

  • intake of dietary supplements and chronic diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01296997

Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Physiology
Jena, Thuringia, Germany, 07743
Sponsors and Collaborators
University of Jena
Principal Investigator: Gerhard Jahreis, Prof. Dr. Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Physiology
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Gerhard Jahreis, Prof. Dr. habil, University of Jena Identifier: NCT01296997     History of Changes
Other Study ID Numbers: LSEP H45-10
Study First Received: February 15, 2011
Last Updated: November 6, 2012

Keywords provided by University of Jena:
calcium phosphate
human study

Additional relevant MeSH terms:
Calcium, Dietary
Bone Density Conservation Agents
Physiological Effects of Drugs
Hormones, Hormone Substitutes, and Hormone Antagonists processed this record on April 28, 2017